Newron announces approval for pivotal Phase III ENIGMA-TRS program with evenamide as add-on therapy in patients with treatment-resistant schizophrenia (TRS)
5 Likes
It really sucks that they had to start over with this drug. Could’ve been approved years ago. Oh well. Hope they let non trs patients try it when it’s finally approved.
1 Like
It’s been more than a decade since this drug is in clinical trials… But I really hope it will help us in the end.
1 Like
I hope with artificial intelligence, organoids and in silico medecine, the drug discovery process would be much more rapid.
3 Likes
It almost certainly will be.
1 Like